## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 2.5% below STRENGTH zone (3.0-6.0%); PEG 2.42 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($517.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Korea Investment CORP Sells 25,341 Shares of Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251202T125117 | Somewhat-Bullish | Relevance: 99%
- Korea Investment CORP reduced its stake in Ulta Beauty Inc. by 46.8% in Q2 2025, selling 25,341 shares and now holding 28,778 shares valued at $13.46 million. This comes as Ulta Beauty exceeded Q2 earnings expectations with $5.78 EPS and $2.79 billion in revenue, leading to a "Moderate Buy" consensus rating from analysts with an average price target of $550.00. Other institutional investors have also adjusted their positions, and Ulta Beauty's stock performance shows a market capitalization of $24.23 billion with a P/E ratio of 20.72.

**2. Jefferies Adjusts Price Target on Ulta Beauty to $565 From $550, Maintains Hold Rating**
- Source: MarketScreener | 20251202T110500 | Somewhat-Bullish | Relevance: 99%
- Jefferies has increased its price target for Ulta Beauty (ULTA) to $565 from $550, while reiterating a Hold rating on the stock. This adjustment comes amidst a series of analyst updates for the beauty retailer, with other firms also revising their price targets and ratings. The article also provides a brief company profile, financial data, and recent news related to Ulta Beauty.

**3. Hsbc Holdings PLC Sells 11,209 Shares of Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251201T095357 | Somewhat-Bullish | Relevance: 99%
- Hsbc Holdings PLC reduced its stake in Ulta Beauty Inc. by 8.4% during Q2 2025, selling 11,209 shares and owning approximately 0.27% of the company worth $57.4 million. Other hedge funds, including J. Safra Sarasin Holding AG and Atria Investments Inc, also adjusted their positions in the specialty retailer. Ulta Beauty reported strong Q2 earnings, beating analyst estimates, and has received a "Moderate Buy" consensus rating from analysts with an average price target of $550.38.

**4. Northwest & Ethical Investments L.P. Makes New Investment in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251130T112420 | Bullish | Relevance: 99%
- Northwest & Ethical Investments L.P. has made a new investment in Ulta Beauty Inc. (NASDAQ:ULTA), acquiring 509 shares valued at approximately $238,000. This new position contributes to the significant institutional ownership of 90.39% in Ulta Beauty, a company that recently beat quarterly estimates and holds a "Moderate Buy" consensus rating from analysts. Other major institutional investors like Price T Rowe Associates Inc. MD, T. Rowe Price Investment Management Inc., JPMorgan Chase & Co., Invesco Ltd., and Franklin Resources Inc. have also recently increased their stakes in Ulta Beauty.

**5. BLI Banque de Luxembourg Investments Lowers Position in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251130T083638 | Neutral | Relevance: 99%
- BLI Banque de Luxembourg Investments reduced its stake in Ulta Beauty Inc. by 6.0% in the second quarter, selling 1,500 shares and holding 23,500 shares valued at $10.77 million. Despite this, other institutional investors like Price T Rowe Associates Inc. MD, T. Rowe Price Investment Management Inc., and JPMorgan Chase & Co. significantly increased their positions in the company. Ulta Beauty's stock currently holds a "Moderate Buy" consensus rating from analysts, with a consensus price target of $550.38, following strong earnings and revenue performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.42 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.9B |
| Beta | 0.87 |
| 52W Range | $309.01 - $611.90 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.42 |
| Forward P/E | 19.5 |
| Current P/E | 21.5 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.4% to 2.5% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.59), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.45% (CS: 86) | Neutral |
| RSI_14 | 62.9 | Neutral |
| MACD Histogram | 4.59 | Bullish |
| vs SMA20 | 1.050x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.186x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $548.05
- **Stop Loss:** $517.15 (5.6% risk)
- **Target:** $578.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $17,537.60
- **Portfolio %:** 17.54%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*